Table 1.
Distributions of characteristics of patients with extra nodal natural killer/T-cell lymphoma, nasal type.
Fig 1.
Kaplan-Meier curves for comparison of patients diagnosed with extra nodal natural killer/T-cell lymphoma, nasal type according to (A) Sex, (B) Age at diagnosis, (C) Ann Arbor Stage and (D) Race.
Table 2.
Survival of 2-, 3- and 5-year follow-up in patients with extra nodal natural killer/T-cell lymphoma, nasal type in 1987–2014.
Table 3.
Hazard ratios and 95% confidence intervals of Cox regression for Mortality Among Patients With extra nodal natural killer/T-cell lymphoma, nasal type Diagnosed Among US Veterans From 1987 to 2014.
Table 4.
Distribution of causes of death of follow-up in patients with extra nodal natural killer/T-cell lymphoma, nasal type, 1987–2014.
Fig 2.
Distribution of causes of death of follow-up in patients with extra nodal natural killer/T-cell lymphoma, nasal type, 1987–2014.
Table 5.
Sub-hazard ratios of cause-specific death by sex, Ann Arbor Stage, calendar year of diagnosis and age at diagnosis by competing-risks regression.
Table 6.
Sub-hazard ratios with 95% confidence intervals of other causes rather than non-Hodgkin’s lymphoma by sex, Ann Arbor Stage, calendar year of diagnosis and age at diagnosis by competing-risks regression.
Fig 3.
Cumulative incidence plot comparing (A) Ann Arbor stage and (B) calendar year of diagnosis in NHL-specific cause mortality.
Fig 4.
Cumulative incidence plot comparing (A) Ann Arbor stage, (B) calendar year of diagnosis (C) age at diagnosis in other cause mortality.
Fig 5.
Cumulative incidence plot comparing (A) calendar year of diagnosis attribute to other tumors, (B) Ann Arbor stage of death attribute to disease of heart, (C) Ann Arbor stage of death attribute to infection and (D) calendar year of diagnosis attribute to infection.